ZINZINO AB (PUBL): Share subscription due to directed offset issue

In accordance with the decision of the Annual General Meeting on May 15, 2022, 94,316 new Zinzino B shares have been issued with payment by offsetting the claim to Kenneth Koh and 63,969 new Zinzino B shares with payment by offsetting the claim to Enhanzz AG. Both transactions are linked to respective acquisitions.

The number of B shares increased by a total of 158,285 to 28,747,171. The total number of shares after the increase amounted to 33,860,563. The dilution amounted to 0.47 percent. Zinzino's share capital increased to SEK 3,386,056.30.

For more information please contact :
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700 , zinzino.com

Images for free publication :
marketing@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifidadviser@penser.se

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.